This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Mitsubishi Tanabe Pharma Corporation. Active years: 2016-2017.
Company Filing History:
Years Active: 2016-2017
Title: Yukie Okamoto: Innovator in Pharmaceutical Chemistry
Introduction
Yukie Okamoto is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of methods for producing valuable compounds. With a total of 2 patents, her work is recognized for its industrial advantages and safety considerations.
Latest Patents
One of her latest patents is a method for producing a 1,4-benzoxazine compound. This invention provides an industrially advantageous approach to creating a compound that is useful as a medicine while minimizing safety and health risks. The method involves three key steps: converting the amino group at the 7-position in a compound into a dimesylamino group, coupling a compound with a boronic acid compound, and converting the 7-position in another compound into a monomesylamino group. The process is designed to enhance the efficiency and safety of pharmaceutical production.
Career Highlights
Yukie Okamoto is currently employed at Mitsubishi Tanabe Pharma Corporation, where she continues to innovate in the pharmaceutical sector. Her work is characterized by a commitment to developing methods that not only advance scientific knowledge but also prioritize the health and safety of end-users.
Collaborations
Throughout her career, Yukie has collaborated with notable colleagues, including Tomoyuki Okabe and Takeshi Hamada. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Yukie Okamoto stands out as a dedicated inventor in the pharmaceutical industry, with her innovative methods contributing to safer and more effective medical solutions. Her work exemplifies the intersection of science and safety in the development of new pharmaceutical compounds.